NCT02954471View on ClinicalTrials.gov

Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia

CompletedOBSERVATIONAL

Enrollment

351

Participants

Timeline

Start Date

October 21, 2016

Primary Completion Date

September 17, 2019

Study Completion Date

September 17, 2019

Conditions

Breast Cancer

Trial Locations (3)

11426

National Guard King Abdulaziz Medical City; Oncology, Riyadh

21499

King Faisal Specialist Hospital & Research Centre, Jeddah

31444

King Fahad Specialist Hospital; Oncology, Dammam

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02954471 - Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi Arabia | Biotech Hunter | Biotech Hunter